Treatment of abnormal increases in gastrointestinal motility with (R)-verapamil
    1.
    发明授权
    Treatment of abnormal increases in gastrointestinal motility with (R)-verapamil 有权
    用(R) - 维拉帕米治疗胃肠蠕动异常增加

    公开(公告)号:US06849661B2

    公开(公告)日:2005-02-01

    申请号:US10294692

    申请日:2002-11-15

    CPC分类号: A61K31/277

    摘要: The present invention is directed to methods of treating, preventing, and/or managing abnormal increases in gastrointestinal motility, and intestinal conditions that cause the same. Such conditions include, but are not limited to, irritable bowel syndrome (IBS), infectious diseases of the small and large intestines, and symptoms of any of the foregoing. In particular, the present invention discloses methods of using enriched (R)-verapamil, as well as compositions and formulations containing the same.

    摘要翻译: 本发明涉及治疗,预防和/或控制胃肠蠕动异常升高和导致其的肠道病症的方法。 这些病症包括但不限于肠易激综合征(IBS),小肠和大肠的感染性疾病以及任何上述症状。 特别地,本发明公开了使用富集的(R) - 维拉帕米以及含有它们的组合物和制剂的方法。